Strategy for how stakeholders and end-users engage with the SHIELD tooling and available knowledge.
Detailed Description
...
Input and output Knowledge (SDC)
...
Analytics
...
Heterogeneous vs Homogeneous representation knowledge
...
Distributed content development
...
Knowledge Provenance (both LIVD config and terminology)
...
Versioning control and modularity
...
Tools to support clinical interoperability must remove the burden of complexity from local laboratories and implementers. For knowledge artifacts that require unified definitions or mappings, repositories should:
Act as a single source of truth
Easily import knowledge (new IVDs, versions, or mappings)
Easily export knowledge (to local users)
Contain all data elements necessary for the defined use cases
Allow distributed content development
Allow version control
Display knowledge provenance and dependency
There are four significant areas of medical knowledge that need to be represented in systems for clinical interoperability to be successful. Attempting to rely on one area (e.g. semantic) without the necessary information from another (e.g. traceability) will result in failure.
Semantic/ontological relationships
Defined terminology mappings assigned to IVDs
Clinical reference standard traceability/harmonization status
Direct comparability of laboratory results requires the knowledge of whether those results are both traceable to a reference standard material or harmonization procedure.
Clinical interpretation data elements
E.g. result value, units, reference range, specimen type
Device/manufacturer data elements
E.g. UDI for device, kit
Supporting Tactics
Tactic | Impact |
---|---|
Laboratory Interoperability Data Resources (LIDR) | Contains necessary class definitions for IVDs and assigned codes |
Controlled Terminology and Semantic Resource | Controlled terminology identifying 1:1 mappings for IVDs and semantic codes |
UDI repositoryRepository | Contains necessary device and IVD information |
Reference Standard/Harmonization Hub | Contains information on what analytes have a traceable standard or harmonization procedure. |
Grouping determination re: standardization/harmonization | Primarily a governance problem: will there be a central location telling people if tests from two different IVDs can be trended together, or will this be left to local judgment? |
Supporting Use Cases
Use Case |
---|
Focus on knowledge behind laboratory data versus opaque information and mapping |
Should be self describingA laboratory is adding a new test to its menu. By querying the LIDR, the laboratory is able to define appropriate terminology code mappings for its test, and they are also able to determine that the test is traceable to an international reference standard. |
A health information exchange (HIE) receives information from an EHR about laboratory tests. They receive information about the test, its code, and the device that performed it, but not the traceability information. They are able to query the central repository to access the missing traceability information. |
A laboratory wants to know if it can safely treat tests from two different IVDs as comparable enough for its clinicians to treat them as interchangeable. The laboratory queries the traceability repository and determines that one of the tests is not standardized or harmonized; it decides not to treat the tests as equivalent. |
Key Initiatives & Action Items
...